Clinical Study

The Effect of Immunonutrition on the Postoperative Complications in Thymoma with Myasthenia Gravis

Table 2

Patient characteristics between two groups.

Immunonutrition
()
Standard nutrition
()

Age>0.05
Gender>0.05
 Male48 (47.1%)67 (47.2%)
 Female54 (52.9)75 (52.8%)
BMI>0.05
Performance status>0.05
 120 (19.6%)30 (21.1%)
 266 (64.7%)92 (64.8%)
 316 (15.7%)20 (14.1%)
Type of thymoma>0.05
 I22 (21.6%)31 (21.8%)
 II78 (76.5%)108 (76.1%)
 III2 (1.9%)3 (2.1)
Type of MG>0.05
 I22 (21.6%)33 (23.2%)
 II63 (61.9)85 (59.9%)
 III12 (11.8%)16 (11.3%)
 IV5 (4.9%)8 (5.6%)
 V00
Operative time (min)>0.05
Pathology>0.05
 A6 (5.9%)8 (5.6%)
 AB42 (41.2%)60 (42.3%)
 B114 (13.7%)19 (13.4%)
 B233 (32.4%)44 (31.0)
 B34 (3.9%)7 (4.9%)
 C3 (2.9)4 (2.8%)
Operative approach>0.05
 Right chest (VATS)74 (72.5%)104 (73.2%)
 Sternal (OPEN)16 (15.7%)22 (15.5%)
 Subxiphoid (VATS)12 (11.8%)16 (11.3%)
Postoperative complications21 (20.6%)35 (24.6%)<0.05
Quantity of drainage<0.05
Hospital stays<0.05